372
E. Tyrrell et al. / Tetrahedron Letters 52 (2011) 369–372
3. Murphy, J. A.; Commeueuc, A. G. J.; Snaddon, T. N.; McGuire, T. M.; Khan, T. A.;
16. De Luca, L.; Giacomelli, G.; Taddei, M. J. Org. Chem. 2001, 2534–2537. CDMT 2-
chloro-4,6-dimethoxy[1,3,5]triazine.
17. Tunoori, A. R.; White, J. M.; Georg, G. I. Org. Lett. 2000, 2, 4091–4093.
18. Legislation requires that an explosives licence is required when using these
reagents see: Wehrstedt, K. D.; Wandrey, P. A.; Heitkamp, D. J. Hazard. Mater.
2005, A126, 1–7.
Hisler, K.; Dewis, M. L.; Carling, M. Org. Lett. 2005, 7, 1427–1429.
4. Taillier, C.; Bellosta, V.; Meyer, C.; Cossy, J. Org. Lett. 2004, 6, 2145–2147.
5. Labeeuw, O.; Phansavath, P.; Genet, J.-P. Tetrahedron Lett. 2004, 45, 7107–7110.
6. Angelastro, M. R.; Mehdi, S.; Burkhart, J. P.; Peet, N. P.; Bey, P. J. Med. Chem.
1990, 33, 13–16.
7. Burke, A. J.; Davies, S. G.; Garner, C. A.; McCarthy, T. D.; Roberts, P. M.; Smith, A.
D.; Rodriguez-Solla, H.; Vickers, R. J. Org. Biomol. Chem. 2004, 2, 1387–1394.
8. Esters and Lactones: (a) D’Aniello, F.; Mann, A.; Taddei, M. J. J. J. Org. Chem.
1996, 61, 4870–4871; (b) Nakamura, S.; Shibasaki, M. Tetrahedron Lett. 1994,
35, 4145–4148; (c) Miyashita, M.; Toshimitu, Y.; Shiratani, T.; Irie, H.
Tetrahedron: Asymmetry 1993, 4, 1573–1578; (d) Furber, M.; Cooper, M. E.;
Donald, D. K. Tetrahedron Lett. 1993, 34, 1351–1354; (e) Garigipati, R. S.;
Tschaen, D. M.; Weinreb, S. M. J. Am. Chem. Soc. 1985, 107, 7790–7792; (f)
Hamada, Y.; Yokokawa, F.; Kabeya, M.; Hatano, K.; Kurono, Y.; Shiori, T.
Tetrahedron 1996, 52, 8297–8306; (g) Marshall, J. A.; Seletsky, B. M.; Luke, G. P.
J. Org. Chem. 1994, 59, 3413–3420; (h) Basha, A.; Lipton, M.; Weinreb, S. M.
Tetrahedron Lett. 1977, 18, 4171–4172; Sterically impeded lactones: (i)
Shimizu, T.; Osako, K.; Nakata, T. Tetrahedron Lett. 1997, 38, 2685–2688; (j)
Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling, U.-H.;
Grabowski, E. J. J. Tetrahedron Lett. 1995, 36, 5461–5464; (k) Roskamp, E. J.;
Burnell, C. C.; Wang, W. B.; Smith, L. A. Synlett 1993, 850–853.
9. (a) Evans, D. A.; Miller, S. J.; Ennis, M. D. J. Org. Chem. 1993, 58, 471–485; (b)
Martin, S. F.; Dodge, J. A.; Burgess, L. E.; Hartmann, M. J. Org. Chem. 1992, 57,
1070–1072; (c) Pearson, C.; Rinehart, K. L.; Sugano, M. Tetrahedron Lett. 1999,
40, 411–414.
10. (a) Moyer, M. P.; Shiruba, J. F.; Rapoport, H. J. Org. Chem. 1986, 51, 5106–5110;
(b) Raghuram, T.; Vijayasaradhi, S.; Singh, J.; Singh, I. Synth. Commun. 1999, 18,
3215–3219.
11. (a) Handa, S.; Gibson, C. L. Tetrahedron: Asymmetry 1996, 7, 1281–1284; (b)
Andersen, R. F.; Coleman, J. E. Tetrahedron Lett. 1997, 38, 317–320; (c)
Armstrong, R. W.; Bauer, S. M.; Kim, S. W. Tetrahedron Lett. 1998, 39, 6993–
6996.
12. Dinh, T. Q.; Armstrong, R. W. Tetrahedron Lett. 1996, 37, 1161–1164.
13. Einhorn, J.; Einhorn, C.; Luche, J. L. Synth. Commun. 1990, 20, 1105–1112.
14. (a) Maugras, I.; Poncet, J.; Jouin, P. Tetrahedron 1990, 46, 2807–2816; (b)
Shreder, K.; Zhang, L.; Goodman, M. Tetrahedron Lett. 1998, 39, 221–224. BOP-
Benzotriazolyloxy-tri-(dimethylamino) phosphonium hexafluorophosphate.
15. Spaltenstein, A.; Leban, J. J.; Huang, J. J.; Reinhardt, K. R.; Viveros, O. H.;
Sigafoos, J.; Crouch, R. Tetrahedron Lett. 1996, 37, 1343–1346.
19. COMU
1-[(1-cyano-2-ethoxy-2oxoethylideneaminooxy)-dimethylamino-
morpholinomethylene)]methanaminium hexafluorophosphate.
20. Subiros-Funosas, R.; Prohens, R.; Barbas, R.; El-Faham, A.; Albericio, F. Eur. J.
Chem. 2009, 15, 9394–9403.
21. (a) El-Faham, A.; Albericio, F. J. Org. Chem. 2008, 73, 2731–2737; (b) Junkers, M.
Aldrich Chemfiles 2010, 10, 10–11.
22. El-Faham, A.; Albericio, F. J. Peptide Sci. 2010, 16, 6–9.
23. Representative procedure: (
alaninamide (5). mixture of DMF (120 mL) containing N,O-
L
)-N-tert-Butyoxycarbonyl-(N0-methoxy-N’-methyl)
A
dimethylhydroxylamine hydrochloride (1.56 g, 0.016 mol) and redistilled
diisopropylethylamine (6.16 g, 0.0477 mol) were cooled to 0 °C in an ice-bath
under
a nitrogen atmosphere. To the mixture was added alanine (3 g,
0.0159 mol) followed by COMU (0.016 mol). The solution immediately
turned yellow and the solution was left stirring in the ice-bath for a further
20 min. The ice-bath was removed and the reaction mixture was allowed to
reach ambient temperature. After about 2 h the colour of the reaction mixture
became orange and stirring was continued for a further 30 min. The solution
was diluted with H2O (200 mL) and extracted with Et2O (3 ꢀ 100 mL). The
combined organic fractions were washed with dilute HCl (1 M) (20 mL),
saturated Na2CO3 solution (3 ꢀ 20 mL) and finally a saturated brine solution
(20 mL). The organic layer was dried over anhydrous MgSO4, filtered in vacuo
and the solvent removed at the pump to afford the title compound as a white
crystalline solid 2.32 g, 63%. Mp 147.2–148.6 °C, lit. 148–153 °C;25
[a
]
D
ꢁ26, c
1, (MeOH), lit. [
a
]
D
ꢁ26, c 1, (MeOH);25 HRMS (EI, M+) calcd for C10H21O4N2
233.1496, found 233.1497; 1H NMR (CDCl3, 400 MHz) d 5.18 (1H, br s, N–H),
4.62 (1H, br s, C–H), 3.70 (3H, s, O–CH3), 3.14 (3H, s, CH3), 1.37 (9H, s, CH3), 1.24
(3H, d J = 7.03 Hz, CH3); 13C (CDCl3 101 MHz) d 18.69, 28.36, 32.16, 46.52,
61.61, 79.50. 155.12,26 173.69.27
24. HPLC was determined using a (Chiralcel-OD-H column) with a Waters 996
photodiode array diode detector. Measurements were made at 230 nm at a
flow rate of 0.5 ml/min. Solvent, hexane/IPA (98:2).
25. The product is commercially available from Aldrich.
26. This resonance was only observed using DEPT Q.
27. This resonance was observed using HMBC.